Concerns following an observation of increased thyroid conditions (including calcitonin, goitre and thyroid) in patients with pre-existing thyroid disease [34] suggest that liraglutide should not be used in patients with such concomitant conditions, and it would seem to be appropriate to discontinue liraglutide should such an illness emerge following treatment initiation. This evidence concerns the gene CALCA and thyroiditis.